Tian Ruo Pu
Director/Board Member presso ONECONNECT FINANCIAL TECHNOLOGY CO., LTD.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Jing Lou | M | 61 | 31 anni | |
Sean Shao | M | 67 |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 16 anni |
Yi Yang | F | 51 | 5 anni | |
Xiao Yu Li | F | 35 | 6 anni | |
Hao Han Xu | M | 29 | 5 anni | |
Chang Yu | M | 66 | 14 anni | |
Chongfeng Shen | M | 54 | 3 anni | |
Tao Wu | M | - | 8 anni | |
Hong Gang Tian | M | 43 | 2 anni | |
Hoi Ti Yang | F | 54 | 3 anni | |
Siu Kuen Lai | F | 48 | 7 anni | |
Koon Wing Ip | M | 63 | 3 anni | |
Jinqiu Tang | M | 41 | 5 anni | |
Zhang Yaolin | M | 66 | 5 anni | |
Xiao Ying Gao | M | 74 |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 13 anni |
Dan Zhang | M | 60 | 2 anni | |
Han Qiu | F | 49 | 8 anni | |
He Yu | M | 67 | 14 anni | |
Quan Long | M | 54 | 3 anni | |
Zhi Jun Liang | M | - | - | |
Joo Yeow Ng | M | 59 | 2 anni | |
Huining Cao | M | 58 |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 14 anni |
Jun Ling Liu | M | 59 | 9 anni | |
Dong Mei Su | M | 54 | 12 anni | |
Dazong Wang | M | 69 | 8 anni | |
Wing Kin Chow | M | 73 | 4 anni | |
Bin Huang | M | 63 | 31 anni | |
Felix Chungfai Wong | M | - |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 12 anni |
Zhi Gang Zhao | M | 64 | 2 anni | |
Keke Ding | F | - | 1 anni | |
Fei Yang | M | - | 4 anni | |
Amit Jindal | M | - |
Accenture AG
Accenture AG Information Technology ServicesTechnology Services Accenture AG provides services and solutions in the areas of strategy, consulting, digital, technology, and operations. The company was founded on August 5, 1983 and is headquartered in Zurich, Switzerland. | 19 anni |
Bibo Xiang | M | 46 | 3 anni | |
Xingyan Gao | F | - | - | |
Xin Fu | F | 45 | 2 anni | |
Rosalie Sagraves | M | 78 |
University of Illinois
| 29 anni |
Chen Xuhua | M | - | 3 anni | |
Fan Lu | M | - | 1 anni | |
Yuan Yuan Ren | M | - | - | |
Xiang He | M | - | 1 anni | |
Dong Tao Luo | M | 48 | 8 anni | |
Jiang Hong | F | - | - | |
Yongtao Luo | M | 49 | - | |
Sunil Pandit | M | - | 3 anni | |
Wen Wei Dou | M | 58 | 7 anni | |
Sterling Song | M | - | - | |
Dan Xie | M | 53 | 12 anni | |
Huang Runzhong | M | 51 | 5 anni | |
Huang Yuxiang | M | 60 | - | |
Yidong Hu | M | 60 | 1 anni | |
Dai Weidong | M | 64 | 9 anni | |
Wen Jun Wang | F | 56 | 3 anni | |
Suli Cui | F | 45 | 6 anni | |
John Sbragia | M | - | 26 anni | |
Dong Cheng | M | 61 | 16 anni | |
Xin Ma | M | 58 | - | |
Yan Zeng | M | 56 | 2 anni | |
Joseph A. Piscopo | M | - |
University of Illinois
| 29 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Shiu Kau Wong | M | 66 | 6 anni | |
Lin Cong | M | 43 | 4 anni | |
Wangchun Ye | M | 69 | 5 anni | |
Zhi Ya Qian | F | 48 | 3 anni | |
Mao Dong Xu | M | 55 | 7 anni | |
Yuen Chong Wai | M | 60 | 2 anni | |
Min Lu | M | 63 | 5 anni | |
Jun Ma | M | 61 | 5 anni | |
Yuyang Cui | M | - | - | |
Feng Pan | M | 46 | - | |
Li Yun Cao | F | 54 | 5 anni | |
Jun Lang Wang | M | - | 1 anni | |
Jian Hua Shao | M | - | 2 anni | |
Yan Kang | M | 52 | 1 anni | |
Liang Qi | M | 51 | 2 anni | |
Christian Guilliod | M | - |
University of Illinois
| 3 anni |
Phil Case | M | - | 5 anni | |
Jian Liu | M | 41 | 2 anni | |
Thomas Meier | M | 54 | 1 anni | |
Luo Ren | M | 66 | 3 anni | |
Duan Wang | M | 54 | 1 anni | |
David Chao | M | 56 | 12 anni | |
Pu Xing | M | 56 | 3 anni | |
Jian Guang Wu | M | 49 | 6 anni | |
Sean Brynjelsen | M | 52 |
University of Illinois
| 6 anni |
Himanshu Shah | M | 58 | 6 anni | |
Bai Chuan Du | M | 77 | 4 anni | |
Robert Piconi | M | 53 |
Kellogg School of Management
| 6 anni |
Kevin D. Schneider | M | 62 | 6 anni | |
Chit Ho | M | 49 | 3 anni | |
Will Price | M | - |
Kellogg School of Management
| 2 anni |
Bo Tan | M | 51 | 10 anni | |
David Parkinson | M | 73 | 7 anni | |
Matthew Murphy | M | - | 6 anni | |
John P. Pascente | M | - |
University of Illinois
| 5 anni |
Rong Chen | F | 55 | 6 anni | |
Jin Jiang | F | - | 1 anni | |
Peter Dobie Everingham | M | 54 | 2 anni | |
Shane McCarthy | M | - |
Kellogg School of Management
| 3 anni |
Graham Goldsmith | M | 63 | 3 anni | |
Yan Jing Jia | F | - | 5 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Cina | 68 | 68.69% |
Stati Uniti | 20 | 20.20% |
Isole Cayman | 15 | 15.15% |
Svizzera | 1 | 1.01% |
Regno Unito | 0 | -.--% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Tian Ruo Pu
- Contatti personali